Company Profile
Pulse Biosciences Stock Price, News & Analysis
Company overview
Business overview
Pulse Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Pulse Biosciences is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Pulse Biosciences follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Pulse Biosciences sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Why the stock is moving
PLSE is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Future catalysts
Pulse Biosciences’s catalysts are Nano-Pulse Stimulation adoption in dermatology and surgery. The market will watch whether the platform keeps moving from interesting technology to repeatable commercial use.
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
ATM Equity Purchases by Pulse Biosciences’ Co-Chairmen Total Approximately $13.3 Million
Source: Pulse Biosciences
- 02
Pulse Biosciences to Present at the BofA Securities 2026 Healthcare Conference
Source: Pulse Biosciences
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.